Clinical Trial Update: Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating the safety and tolerability of vertebral bone marrow-derived mesenchymal stem cells (BM-MSC) in real-world …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplant

Drugs mentioned

• Vertebral bone marrow-derived mesenchymal stem cells (BM-MSC)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Kidney Diseases, Kidney Transplant | Status: RECRUITING